Thermal Ablation of T1a Renal Cell Carcinoma: The Clinical Evidence

Abstract Renal cell carcinoma (RCC) is most commonly diagnosed at an early (T1a) stage and is typically amenable to several effective treatments. The current gold standard therapy is partial nephrectomy, given its decreased morbidity and similar oncologic outcomes when compared with radical nephrect...

Full description

Saved in:
Bibliographic Details
Published in:Seminars in interventional radiology 2019-12, Vol.36 (5), p.367-373
Main Authors: Young, Shamar, Golzarian, Jafar, Anderson, J. Kyle
Format: Article
Language:English
Subjects:
Review
Review Article
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Renal cell carcinoma (RCC) is most commonly diagnosed at an early (T1a) stage and is typically amenable to several effective treatments. The current gold standard therapy is partial nephrectomy, given its decreased morbidity and similar oncologic outcomes when compared with radical nephrectomy. Thermal ablation is an evolving definitive therapy for T1a RCC which is even less invasive than partial nephrectomy. This article reviews the evidence for thermal ablation in the treatment of T1a RCC and compares outcomes of existing ablation modalities with surgical management.
ISSN:0739-9529
1098-8963
DOI:10.1055/s-0039-1696650